Times Square Capital Management, LLC Pulmonx Corp Transaction History

Times Square Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$15.35 - $23.99 $146,592 - $229,104	9,550 Added 0.79%	1,223,754 $20.4 Million
Q2 2022 Aug 05, 2022	BUY	$14.0 - $27.95 $1.96 Million - $3.92 Million	140,300 Added 13.06%	1,214,204 $17.9 Million
Q1 2022 May 06, 2022	SELL	$21.13 - $35.65 $3.83 Million - $6.46 Million	-181,196 Reduced 14.44%	1,073,904 $26.6 Million
Q4 2021 Feb 04, 2022	SELL	$29.72 - $45.1 $526,935 - $799,623	-17,730 Reduced 1.39%	1,255,100 $40.3 Million
Q3 2021 Nov 08, 2021	BUY	$35.98 - $44.48 $22.4 Million - $27.7 Million	621,720 Added 95.49%	1,272,830 $45.8 Million
Q2 2021 Aug 09, 2021	BUY	$37.61 - $48.0 $11.2 Million - $14.4 Million	299,110 Added 84.97%	651,110 $28.7 Million
Q1 2021 May 12, 2021	BUY	$44.0 - $67.54 $1.35 Million - $2.07 Million	30,600 Added 9.52%	352,000 $16.1 Million
Q4 2020 Feb 12, 2021	BUY	$39.31 - $69.02 $12.6 Million - $22.2 Million	321,400 New	321,400 $22.2 Million

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.